Compression Therapy Market by Technique (Static, Dynamic), Product (Garments (Stockings, Bandages, Wraps), Ortho Braces, Pump), Application (Varicose Vein, DVT, Lymphedema, Leg Ulcer), Distribution (Clinics, Pharmacies, E-Comm) - Global Forecasts to 2026
The compression therapy market size is projected to reach USD 3.9 billion by 2026, at a CAGR of 5.2%. The presence of a significant target patient base and the rising incidence of sports injuries & accidents are the major factors driving the growth of this market.
However, poor patient compliance for compression garments and the lack of universally accepted standards for compression products are the key factors that are expected to restrain the growth of this market during the forecast period.
Attractive growth opportunities in global compression therapy market
There is increased number of clinical research studies those suggest the advantages of using compression garments during streanous physical activities, however, there is no clearly defined or globally acceptable quality parameters for product manufacturing. Further, we have observed that several product manufacturers are increasingly focused on improve their product quality (such as use of polyamide & elastomeric fabrics), continued replacement of woven facbrics by flat or circular knitting for product manufacturing, and portfolio expansion for gender neutral or aesthetic products for wider user acceptance.
Also, sensor-embedded or smart apparels are expected to be a major disruption in the compression garments market owing to underlying factors such as real-time patient monitoring for critical conditions (such as pulse rate, temperature, blood pressure, etc.) that offers early disease diagnosis.
To know about the assumptions considered for the study, Request for Free Sample Report
Compression Therapy Market Global Dynamics
Drivers: Presence of a large target patient population
The target population for compression therapy products includes patients suffering from lifestyle-related diseases and vascular diseases, such as obesity, diabetes, lymphedema, DVT, and varicose veins. The rising geriatric population across the globe is considered a major factor supporting market growth as geriatric individuals are more susceptible to various health conditions. These factors are driving the demand and adoption of various treatment procedures, including compression therapy, among patients. Moreover, compression therapy products are increasingly being preferred as the first line of treatment for major target indications and for post-surgery rehabilitation.
Restraints: Lack of universally accepted standards for compression products
The lack of uniform international pressure standards for compression therapy garments across the globe may cause confusion regarding the selection of the garment for the treatment of different diseases. Globally, several standards, including the German RAL, French ASQUL, and British standards, exist with different pressure specifications included in each standard. For instance, as per the British, French, and German standards, the pressure applied by Class I compression hosiery should be 14–17 mmHg, 15 mmHg, and 18–21 mmHg, respectively. Additionally, the US FDA does not have any set standards for compression garments. Currently, the pressure exerted by stockings is determined by manufacturers on the basis of their laboratory measurements due to the lack of uniform standards for graduated compression stockings worldwide. In addition, factors such as the elasticity and stiffness of stocking material and the size and shape of a patient’s legs can affect the overall pressure exerted by the garment. Considering the lack of uniform standards in the market, a wide range of products are offered at different price points with varying levels of medical efficacy. The varying efficacy of these products can potentially hamper customer trust in compression therapy, thereby restraining the growth of this market.
Opportunities: Growth potential offered by emerging markets
Emerging economies such as China, India, Brazil, and Mexico are expected to offer significant growth opportunities for players operating in the compression therapy market during the forecast period. Factors such as the presence of a large patient population, rising healthcare expenditure, increasing disposable income levels, and growing awareness among physicians, surgeons, and patients about the latest treatment options available for various orthopedic and vascular disorders are expected to drive the demand for compression therapy products in these countries. Asia is home to a large and rapidly growing patient population for target diseases, such as diabetes and cancer. Moreover, the geriatric population in Asia is expected to increase significantly in the coming years, which will further increase the prevalence of target diseases in the region. For instance, between 2015 and 2040, the diabetes population in Southeast Asia is estimated to increase from 78.3 million to 140.2 million; this figure is expected to increase from 153.2 million to 241.8 million across Western Pacific countries during the same period (Source: IDF). Considering the potential growth opportunities in these regions, prominent as well as emerging product manufacturers in the orthopedic and medical device industries are increasingly focusing on expanding their business across emerging Asian and LATAM countries in order to increase their profitability and strengthen their presence in the global compression therapy market.
Challenges: Significant adoption of alternative therapies for specific target indications
Several treatment options, including surgeries, ablation procedures, sclerotherapy, and ligation, are available for chronic venous diseases such as chronic venous insufficiency, varicose veins & spider veins, leg swelling and pain, and leg ulcers. Though compression therapy is considered as the first-line treatment for these diseases, several alternative therapies offer benefits (over compression therapy) such as few or no complications, minimal pain during and after treatment, and reduced hospital stay. Also, unlike compression therapy, these alternative therapies cure the disease and not just the symptoms. For instance, varicose veins are majorly treated with ablation procedures, such as laser and radiofrequency ablation. These ablation procedures are performed with local anesthetics and typically require no sedation. Likewise, DVT is commonly treated with anticoagulants such as heparin and warfarin. Considering the potential benefits of these alternative therapies, their preference has increased among patients as well as healthcare providers over the years. This is considered a major challenge for the growth of the compression therapy market in the coming years.
As of 2021, Compression garments were the largest product segment in compression therapy market
Based on product, the compression therapy market is segmented into compression garments, compression braces, and compression pumps. Compression garments were estimated to account for the largest share of the compression therapy market in 2021. Their dominant position is majorly be attributed to their wide application profile (such as varicose veins, edema, DVT) and established adoption in major markets for the management of several chronic conditions.
As of 2021, Lymphedema treatment is poised to be the fastest-growing application segment in the compression therapy market
On the basis of application, the compression therapy market is segmented into varicose vein treatment, deep vein thrombosis treatment, lymphedema treatment, leg ulcer treatment, and other applications. The lymphedema treatment was poised to be the fastest growing application segment for compression therapy products owing to higher utilization of compression garments as an adjunct treatment coupled with rising incidence of lymphedema across major geographies and greater availability of reimbursements for the same.
North America is estimated to be the largest regional market for compression therapy products in 2021
In 2021, North America is expected to account for the largest share of the compression therapy market. This can majorly be attributed to the rising number of orthopedic and spinal surgeries; growing number of patients suffering from DVT, varicose veins, and lymphedema; increasing incidence of sports injuries; and the presence of a number of compression therapy product manufacturers in the region.
To know about the assumptions considered for the study, download the pdf brochure
Compression Therapy Market Key Players
Prominent players operating in the global compression therapy market are DJO Global, Inc. (US), BSN medical (US), medi GmbH & Co. KG (Germany), Tactile Medical (US), SIGVARIS (Switzerland), Paul Hartmann AG (Germany), Sanyleg S.r.l. (Italy), 3M (US), ConvaTec Inc. (US), ArjoHuntleigh (Sweden), Julius Zorn GmbH (Germany), Bio Compression Systems, Inc. (US), Cardinal Health, Inc. (US), and Smith & Nephew plc (UK).
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
|
Report Metric |
Details |
|
Market Size available for years |
2019–2026 |
|
Base year considered |
2020 |
|
Forecast period |
2022–2026 |
|
Forecast units |
Value (USD Billion) |
|
Segments covered |
Product, Technique, Application, Distribution Channel, And Region |
|
Geographies covered |
North America, Europe, Latin America, Asia Pacific, and Middle East & Africa |
|
Companies covered |
DJO Global, Inc. (US), BSN medical (US), medi GmbH & Co. KG (Germany), Tactile Medical (US), SIGVARIS (Switzerland), Paul Hartmann AG (Germany), Sanyleg S.r.l. (Italy), 3M (US), ConvaTec Inc. (US), ArjoHuntleigh (Sweden), Julius Zorn GmbH (Germany), Bio Compression Systems, Inc. (US), Cardinal Health, Inc. (US), and Smith & Nephew plc (UK) |
This research report categorizes the compression therapy market based on product, technique, application, distribution channel, and region
By Product
- Compression Garments
- Compression Stockings
- Compression Bandages & Wraps
- Other Compression Garments*
- Compression Braces
- Compression Pumps
- *Other compression garments include foot caps, arm sleeves, gauntlets, compression shirts and bras, chin straps, face masks, and abdominal gloves.
By Technique
- Static Compression Therapy
- Dynamic Compression Therapy
By Application:
- Varicose Vein Treatment
- Deep Vein Thrombosis Treatment
- Lymphedema Treatment
- Leg Ulcer Treatment
- Other Applications**
- **Other applications include the use of compression therapy during traveling, pregnancy, foot ulcers, and leg pain
By Distribution Channel
- Pharmacies & Retailers
- Hospitals & Clinics
- E-Commerce Platforms
By Region
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- RoE
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- RoLA
- Middle East & Africa
Recent Developments:
- In 2021, Essity acquired with ABIGO Medical. The acquisition added to the company’s wound care product portfolio.
- In 2021, DJO acquired MedShape, Inc. (US). This acquisition will strengthen DJO’s portfolio of fracture fixation, joint fusion, and soft tissue injury repair products, which utilize biomaterial technologies designed to improve patient outcomes.
- In 2020, medi GmbH & co. KG launched mediven cosy 450, which added to its flat-knit compression portfolio
Frequently Asked Questions (FAQ):
What is the addressable market value of compression therapy over a 5-year period?
The global compression therapy market is valued at USD 3.0 billion in 2021 and is expected to reach USD 3.9 billion by 2026, at a CAGR of 5.2% during the forecast period.
Which product segment is expected to garner highest traction within the compression therapy market?
Based on product, the compression therapy market is segmented into compression garments, compression braces, and compression pumps. Compression garments are expected to account for the largest share of the compression therapy market in 2021. This can majorly be attributed to the use of compression garments in a wide range of indications, such as varicose veins, edema, DVT, and lymphedema, as well as in the management of several chronic conditions.
What are the strategies adopted by the top market players to penetrate across emerging regions?
The key growth strategies adopted by the top players in this market include product launches and approvals; agreements and partnerships; expansions; and acquisitions.
What is the adoption pattern for compression therapy across major healthcare markets?
In 2021, North America is expected to account for the largest share of the compression therapy market. This can majorly be attributed to the rising number of orthopedic and spinal surgeries; growing number of patients suffering from DVT, varicose veins, and lymphedema; increasing incidence of sports injuries; and the presence of a number of compression therapy product manufacturers in the region. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 28)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.5 LIMITATIONS
1.6 MARKET STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 34)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 2 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2 MARKET ESTIMATION METHODOLOGY
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2 SALES/DISTRIBUTION CHANNEL-BASED MARKET ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: GLOBAL COMPRESSION THERAPY MARKET
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 COVID-19 HEALTH ASSESSMENT
2.4 COVID-19 ECONOMIC ASSESSMENT
2.5 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 6 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 7 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
2.6 DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION
2.7 RESEARCH ASSUMPTIONS
2.8 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY (Page No. - 48)
FIGURE 9 COMPRESSION THERAPY MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 10 GLOBAL MARKET SHARE, BY TECHNIQUE, 2021 VS. 2026
FIGURE 11 GLOBAL MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 12 GLOBAL MARKET SHARE, BY DISTRIBUTION CHANNEL, 2021 VS. 2026
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL MARKET
4 PREMIUM INSIGHTS (Page No. - 52)
4.1 COMPRESSION THERAPY MARKET OVERVIEW
4.2 GLOBAL MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 14 COMPRESSION PUMPS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
4.3 GLOBAL MARKET, BY TECHNIQUE, 2021 VS. 2026 (USD MILLION)
FIGURE 15 DYNAMIC COMPRESSION THERAPY SEGMENT TO WITNESS THE HIGHEST GROWTH FROM 2021 TO 2026
4.4 GLOBAL MARKET, BY DISTRIBUTION CHANNEL, 2021 VS. 2026 (USD MILLION)
FIGURE 16 PHARMACIES & RETAILERS SEGMENT TO DOMINATE THE COMPRESSION THERAPY MARKET IN 2026
4.5 GLOBAL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 ASIA PACIFIC IS A LUCRATIVE MARKET FOR THE MANUFACTURERS OF COMPRESSION THERAPY PRODUCTS
5 MARKET OVERVIEW (Page No. - 55)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 GLOBAL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Presence of a large target patient population
FIGURE 19 GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 VS. 2050
5.2.1.2 Increasing incidence of sports injuries and accidents
FIGURE 20 EUROPE: NUMBER OF ROAD ACCIDENTS, BY COUNTRY, 2016
5.2.1.3 Increasing number of orthopedic procedures
5.2.1.4 Greater product affordability and market availability
5.2.1.5 Clinical evidence favoring the adoption of compression therapy in the management of target conditions
5.2.2 RESTRAINTS
5.2.2.1 Lack of universally accepted standards for compression products
5.2.2.2 Low patient compliance for compression garments
FIGURE 21 REASONS FOR NON-COMPLIANCE TO COMPRESSION THERAPY
5.2.3 OPPORTUNITIES
5.2.3.1 Growth potential offered by emerging markets
5.2.3.2 Rising patient awareness regarding the benefits of compression therapy in target disease management
5.2.3.3 Increased sales of off-the-shelf and online products
5.2.4 CHALLENGES
5.2.4.1 Significant adoption of alternative therapies for specific target indications
5.2.4.2 Increasing pricing pressure on market players
5.3 COVID-19 IMPACT TRENDS
5.4 PORTER’S FIVE FORCES
5.4.1 OVERVIEW
TABLE 2 COMPRESSION THERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS
5.4.2 BARGAINING POWER OF BUYERS
5.4.3 BARGAINING POWER OF SUPPLIERS
5.4.4 THREAT OF NEW ENTRANTS
5.4.5 THREAT OF SUBSTITUTES
5.4.6 INTENSITY OF COMPETITIVE RIVALRY
5.5 PRICING TREND ANALYSIS
TABLE 3 REGIONAL PRICING ANALYSIS OF KEY COMPRESSION THERAPY PRODUCTS, 2020 (USD)
5.6 REGULATORY ANALYSIS
5.6.1 NORTH AMERICA
5.6.1.1 US
TABLE 4 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.6.1.2 Canada
TABLE 6 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 22 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
5.6.2 EUROPE
FIGURE 23 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
5.6.3 ASIA PACIFIC
5.6.3.1 Japan
TABLE 7 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.6.3.2 China
TABLE 8 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.6.3.3 India
5.7 REIMBURSEMENT SCENARIO
TABLE 9 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES AS OF 2021
5.8 VALUE CHAIN ANALYSIS
FIGURE 24 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING THE MANUFACTURING PHASE
5.9 SUPPLY CHAIN ANALYSIS
5.9.1 PROMINENT COMPANIES
5.9.2 SMALL & MEDIUM-SIZED ENTERPRISES
5.9.3 END USERS
FIGURE 25 SUPPLY CHAIN ANALYSIS
5.10 ECOSYSTEM LANDSCAPE
5.10.1 PARENT MARKET: ORTHOPEDIC IMPLANTS, SURGICAL DEVICES, AND SUPPORT PRODUCTS
5.11 PATENT ANALYSIS
FIGURE 26 PATENT ANALYSIS
6 COMPRESSION THERAPY MARKET, BY TECHNIQUE (Page No. - 81)
6.1 INTRODUCTION
TABLE 10 GLOBAL MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
6.2 STATIC COMPRESSION THERAPY
6.2.1 STATIC COMPRESSION THERAPY PROVIDES PROCEDURAL ADVANTAGES IN DISEASE MANAGEMENT
TABLE 11 STATIC COMPRESSION THERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3 DYNAMIC COMPRESSION THERAPY
6.3.1 RISING INCIDENCE OF TARGET CONDITIONS IS A KEY FACTOR DRIVING MARKET GROWTH
TABLE 12 DYNAMIC COMPRESSION THERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
7 COMPRESSION THERAPY MARKET, BY PRODUCT (Page No. - 85)
7.1 INTRODUCTION
TABLE 13 GLOBAL MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
7.2 COMPRESSION GARMENTS
TABLE 14 COMPRESSION GARMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 15 COMPRESSION GARMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
7.2.1 COMPRESSION GARMENTS MARKET SPLIT, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 16 COMPRESSION GARMENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
7.2.2 COMPRESSION GARMENTS MARKET SPLIT, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 17 COMPRESSION GARMENTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
7.2.3 COMPRESSION GARMENTS MARKET SPLIT, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
TABLE 18 COMPRESSION GARMENTS MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
7.2.3.1 Compression bandages & wraps
7.2.3.1.1 Limited availability of medical reimbursements for varicose vein surgeries to restrain the market growth
TABLE 19 COMPRESSION BANDAGES & WRAPS MARKET, BY REGION, 2019–2026 (USD MILLION)
7.2.3.1.2 Compression bandages & wraps market split, by technique, 2019–2026 (USD million)
TABLE 20 COMPRESSION BANDAGES & WRAPS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
7.2.3.1.3 Compression bandages & wraps market split, by application, 2019–2026 (USD Million)
TABLE 21 COMPRESSION BANDAGES & WRAPS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
7.2.3.1.4 Compression bandages & wraps market split, by distribution channel, 2019–2026 (USD Million)
TABLE 22 COMPRESSION BANDAGES & WRAPS MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
7.2.3.2 Compression stockings
7.2.3.2.1 Use of compression stockings in the long-term management of venous diseases to support market growth
TABLE 23 COMPRESSION STOCKINGS MARKET, BY REGION, 2019–2026 (USD MILLION)
7.2.3.2.2 Compression stockings market split, by technique, 2019–2026 (USD Million)
TABLE 24 COMPRESSION STOCKINGS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
7.2.3.2.3 Compression stockings market split, by application, 2019–2026 (USD Million)
TABLE 25 COMPRESSION STOCKINGS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
7.2.3.2.4 Compression stockings market split, by distribution channel, 2019–2026 (USD Million)
TABLE 26 COMPRESSION STOCKINGS MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
7.2.3.3 Other compression garments
TABLE 27 OTHER COMPRESSION GARMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
7.2.3.3.1 Other compression garments market split, by technique, 2019–2026 (USD Million)
TABLE 28 OTHER COMPRESSION GARMENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
7.2.3.3.2 Other compression garments market split, by application, 2019–2026 (USD Million)
TABLE 29 OTHER COMPRESSION GARMENTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
7.2.3.3.3 Other compression garments market split, by distribution channel, 2019–2026 (USD Million)
TABLE 30 OTHER COMPRESSION GARMENTS MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
7.3 COMPRESSION PUMPS
7.3.1 RISING PREVALENCE OF CHRONIC VENOUS DISEASES TO DRIVE MARKET GROWTH
TABLE 31 COMPRESSION PUMPS MARKET, BY REGION, 2019–2026 (USD MILLION)
7.3.2 COMPRESSION PUMPS MARKET SPLIT, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 32 COMPRESSION PUMPS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
7.3.3 COMPRESSION PUMPS MARKET SPLIT, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 33 COMPRESSION PUMPS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
7.3.4 COMPRESSION PUMPS MARKET SPLIT, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
TABLE 34 COMPRESSION PUMPS MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
7.4 COMPRESSION BRACES
7.4.1 RISING NUMBER OF JOINT REPLACEMENT SURGERIES TO SUPPORT MARKET GROWTH
TABLE 35 COMPRESSION BRACES MARKET, BY REGION, 2019–2026 (USD MILLION)
7.4.2 COMPRESSION BRACES MARKET SPLIT, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 36 COMPRESSION BRACES MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
7.4.3 COMPRESSION BRACES MARKET SPLIT, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 37 COMPRESSION BRACES MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
7.4.4 COMPRESSION BRACES MARKET SPLIT, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
TABLE 38 COMPRESSION BRACES MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
8 COMPRESSION THERAPY MARKET, BY APPLICATION (Page No. - 100)
8.1 INTRODUCTION
TABLE 39 GLOBAL MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
8.2 VARICOSE VEIN TREATMENT
8.2.1 COMPRESSION THERAPY IS CONSIDERED AS THE FIRST LINE OF TREATMENT FOR VARICOSE VEINS
TABLE 40 GLOBAL MARKET FOR VARICOSE VEIN TREATMENT, BY REGION, 2019–2026 (USD MILLION)
8.3 DEEP VEIN THROMBOSIS TREATMENT
8.3.1 AVAILABILITY OF ALTERNATIVE TREATMENTS FOR DVT TO LIMIT MARKET GROWTH
TABLE 41 GLOBAL MARKET FOR DEEP VEIN THROMBOSIS TREATMENT, BY REGION, 2019–2026 (USD MILLION)
8.4 LYMPHEDEMA TREATMENT
8.4.1 RISING INCIDENCE OF CANCER TO SUPPORT MARKET GROWTH
TABLE 42 COMPRESSION THERAPY MARKET FOR LYMPHEDEMA TREATMENT, BY REGION, 2019–2026 (USD MILLION)
8.5 LEG ULCER TREATMENT
8.5.1 GROWING DISEASE BURDEN ACROSS MAJOR COUNTRIES TO SUPPORT MARKET GROWTH
TABLE 43 GLOBAL MARKET FOR LEG ULCER TREATMENT, BY REGION, 2019–2026 (USD MILLION)
8.6 OTHER APPLICATIONS
TABLE 44 GLOBAL MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
9 COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL (Page No. - 107)
9.1 INTRODUCTION
TABLE 45 GLOBAL MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
9.2 PHARMACIES & RETAILERS
9.2.1 RISING ADOPTION OF OFF-THE-SHELF PRODUCTS TO SUPPORT MARKET GROWTH
TABLE 46 COMPRESSION THERAPY MARKET FOR PHARMACIES & RETAILERS, BY REGION, 2019–2026 (USD MILLION)
9.3 E-COMMERCE PLATFORMS
9.3.1 E-COMMERCE PLATFORMS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
TABLE 47 GLOBAL MARKET FOR E-COMMERCE PLATFORMS, BY REGION, 2019–2026 (USD MILLION)
9.4 HOSPITALS & CLINICS
9.4.1 HEALTHCARE INFRASTRUCTURE IMPROVEMENTS TO SUPPORT MARKET GROWTH
TABLE 48 COMPRESSION THERAPY MARKET FOR HOSPITALS & CLINICS, BY REGION, 2019–2026 (USD MILLION)
10 COMPRESSION THERAPY MARKET, BY REGION (Page No. - 111)
10.1 INTRODUCTION
TABLE 49 COMPRESSION THERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 27 NORTH AMERICA: COMPRESSION THERAPY MARKET SNAPSHOT
TABLE 50 NORTH AMERICA: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 51 NORTH AMERICA: MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 52 NORTH AMERICA: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 53 NORTH AMERICA: COMPRESSION GARMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 54 NORTH AMERICA: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 55 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.2.1 US
10.2.1.1 Rising number of sports injuries to drive market growth
TABLE 56 US: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 57 US: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 58 US: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 59 US: MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Increasing incidence of target diseases is the major factor supporting market growth in Canada
TABLE 60 CANADA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 61 CANADA: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 62 CANADA: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 63 CANADA: MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.3 EUROPE
TABLE 64 EUROPE: COMPRESSION THERAPY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 65 EUROPE: MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 66 EUROPE: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 67 EUROPE: COMPRESSION GARMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 68 EUROPE: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 69 EUROPE: MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Inconsistent reimbursement for compression therapy products to restrain market growth to a certain extent in Germany
TABLE 70 GERMANY: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 71 GERMANY: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 72 GERMANY: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 73 GERMANY: MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.3.2 UK
10.3.2.1 Rising prevalence of lymphedema and DVT to drive market growth
TABLE 74 UK: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 75 UK: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 76 UK: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 77 UK: MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Increasing incidence of target indications will increase the demand for compression therapy
TABLE 78 FRANCE: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 79 FRANCE: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 80 FRANCE: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 81 FRANCE MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Rising awareness about preventive care for musculoskeletal injuries to support market growth
TABLE 82 ITALY: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 83 ITALY: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 84 ITALY: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 85 ITALY: MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Rising prevalence of target diseases to support market growth in Spain
TABLE 86 SPAIN: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 87 SPAIN: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 88 SPAIN: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 89 SPAIN: MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 90 ROE: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 91 ROE: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 92 ROE: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 93 ROE: MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 28 ASIA PACIFIC: COMPRESSION THERAPY MARKET SNAPSHOT
TABLE 94 ASIA PACIFIC: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 95 ASIA PACIFIC: MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 96 ASIA PACIFIC: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 97 ASIA PACIFIC COMPRESSION GARMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 98 ASIA PACIFIC: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 99 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Japan dominates the APAC compression therapy market
TABLE 100 JAPAN: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 101 JAPAN: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 102 JAPAN: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 103 JAPAN: MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Expansion of the target patient population and modernization of healthcare facilities to drive market growth in China
TABLE 104 CHINA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 105 CHINA: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 106 CHINA: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 107 CHINA: MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Growing number of hip & knee surgeries to support market growth
TABLE 108 INDIA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 109 INDIA: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 110 INDIA: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 111 INDIA: MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.4.4 AUSTRALIA
10.4.4.1 Government subsidies for purchasing compression garments for lymphedema patients to support market growth
TABLE 112 AUSTRALIA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 113 AUSTRALIA: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 114 AUSTRALIA: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 115 AUSTRALIA: MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.4.5 SOUTH KOREA
10.4.5.1 Increasing number of plastic surgeries in the country to drive the demand for compression garments
TABLE 116 SOUTH KOREA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 117 SOUTH KOREA: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 118 SOUTH KOREA: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 119 SOUTH KOREA MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.4.6 REST OF ASIA PACIFIC
TABLE 120 ROAPAC: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 121 ROAPAC: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 122 ROAPAC: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 123 ROAPAC: MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.4.7 LATIN AMERICA
TABLE 124 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 125 LATIN AMERICA: MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 126 LATIN AMERICA: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 127 LATIN AMERICA: COMPRESSION GARMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 128 LATIN AMERICA: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 129 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.4.7.1 Brazil
10.4.7.1.1 Rising number of cosmetic surgeries to support market growth in Brazil
TABLE 130 BRAZIL: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 131 BRAZIL: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 132 BRAZIL: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 133 BRAZIL: MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.4.7.2 Mexico
10.4.7.2.1 Rising prevalence of target diseases to support market growth in Mexico
TABLE 134 MEXICO: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 135 MEXICO: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 136 MEXICO: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 137 MEXICO: MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.4.7.3 Rest of Latin America
TABLE 138 ROLATAM: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 139 ROLATAM: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 140 ROLATAM: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 141 ROLATAM: MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.4.8 MIDDLE EAST & AFRICA
10.4.8.1 Unfavorable reimbursement scenario to hamper the market growth in the MEA
TABLE 142 MEA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 143 MEA: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 144 MEA: COMPRESSION GARMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 145 MEA: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 146 MEA: MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
11 COMPETITIVE LANDSCAPE (Page No. - 162)
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE COMPRESSION THERAPY MARKET
TABLE 147 STRATEGIES ADOPTED BY KEY COMPRESSION THERAPY PRODUCT MANUFACTURING COMPANIES
11.3 REVENUE SHARE ANALYSIS
FIGURE 29 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE COMPRESSION THERAPY MARKET
11.4 MARKET SHARE ANALYSIS
FIGURE 30 COMPRESSION THERAPY MARKET SHARE, BY KEY PLAYER, 2020
11.5 COMPETITIVE SITUATIONS AND TRENDS
TABLE 148 COMPRESSION THERAPY MARKET: DEGREE OF COMPETITION
11.6 COMPANY EVALUATION QUADRANT
11.7 COMPETITIVE LEADERSHIP MAPPING
11.7.1 STARS
11.7.2 EMERGING LEADERS
11.7.3 PERVASIVE PLAYERS
11.7.4 PARTICIPANTS
FIGURE 31 COMPRESSION THERAPY MARKET (GLOBAL): COMPANY EVALUATION MATRIX, 2020
11.8 COMPETITIVE EVALUATION QUADRANT FOR SMES/START-UPS
11.8.1 PROGRESSIVE COMPANIES
11.8.2 STARTING BLOCKS
11.8.3 RESPONSIVE COMPANIES
11.8.4 DYNAMIC COMPANIES
FIGURE 32 COMPRESSION THERAPY MARKET: COMPANY EVALUATION MATRIX FOR SMES/START-UPS, 2020
11.9 COMPETITIVE BENCHMARKING
FIGURE 33 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE COMPRESSION THERAPY MARKET
TABLE 149 COMPANY PRODUCT FOOTPRINT
TABLE 150 COMPANY GEOGRAPHICAL FOOTPRINT
11.10 COMPETITIVE SCENARIO
TABLE 151 PRODUCT LAUNCHES & ENHANCEMENTS
TABLE 152 DEALS
12 COMPANY PROFILES (Page No. - 173)
12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 3M
TABLE 153 3M: BUSINESS OVERVIEW
FIGURE 34 3M: COMPANY SNAPSHOT (2020)
12.1.2 ARJOHUNTLEIGH
TABLE 154 ARJOHUNTLEIGH: BUSINESS OVERVIEW
FIGURE 35 ARJOHUNTLEIGH: COMPANY SNAPSHOT (2020)
12.1.3 BIO COMPRESSION SYSTEMS, INC.
TABLE 155 BIO COMPRESSION SYSTEMS, INC.: BUSINESS OVERVIEW
12.1.4 BSN MEDICAL
TABLE 156 ESSITY: BUSINESS OVERVIEW
FIGURE 36 ESSITY: COMPANY SNAPSHOT (2020)
12.1.5 CARDINAL HEALTH
TABLE 157 CARDINAL HEALTH: BUSINESS OVERVIEW
FIGURE 37 CARDINAL HEALTH: COMPANY SNAPSHOT (2020)
12.1.6 CONVATEC INC.
TABLE 158 CONVATEC INC.: BUSINESS OVERVIEW
FIGURE 38 CONVATEC INC.: COMPANY SNAPSHOT (2020)
12.1.7 DJO, INC. (A SUBSIDIARY OF COLFAX CORPORATION)
TABLE 159 DJO, INC.: BUSINESS OVERVIEW
FIGURE 39 COLFAX CORPORATION: COMPANY SNAPSHOT (2020)
12.1.8 JULIUS ZORN GMBH
TABLE 160 JULIUS ZORN GMBH: BUSINESS OVERVIEW
12.1.9 MEDI GMBH & CO. KG
TABLE 161 MEDI GMBH & CO. KG: BUSINESS OVERVIEW
12.1.10 PAUL HARTMANN AG
TABLE 162 PAUL HARTMANN AG: BUSINESS OVERVIEW
FIGURE 40 PAUL HARTMANN AG: COMPANY SNAPSHOT (2020)
12.1.11 SANYLEG S.R.L.
TABLE 163 SANYLEG S.R.L.: BUSINESS OVERVIEW
12.1.12 SIGVARIS GROUP
TABLE 164 SIGVARIS GROUP: BUSINESS OVERVIEW
12.1.13 SMITH & NEPHEW PLC
TABLE 165 SMITH & NEPHEW PLC: BUSINESS OVERVIEW
FIGURE 41 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2020)
12.1.14 TACTILE MEDICAL
TABLE 166 TACTILE MEDICAL: BUSINESS OVERVIEW
FIGURE 42 TACTILE MEDICAL: COMPANY SNAPSHOT (2020)
12.2 OTHER PLAYERS
12.2.1 GOTTFRIED MEDICAL, INC.
TABLE 167 GOTTFRIED MEDICAL, INC.: BUSINESS OVERVIEW
12.2.2 THERMOTEK, INC.
TABLE 168 THERMOTEK, INC.: BUSINESS OVERVIEW
12.2.3 BAUERFEIND AG
TABLE 169 BAUERFEIND AG: BUSINESS OVERVIEW
12.2.4 OFA BAMBERG GMBH
TABLE 170 OFA BAMBERG GMBH: BUSINESS OVERVIEW
12.2.5 ACI MEDICAL, LLC
TABLE 171 ACI MEDICAL, LLC: BUSINESS OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX (Page No. - 217)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
This study involved four major activities in estimating the current size of the compression therapy market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and market sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were used to estimate the total market size. After that, the market breakdown and data triangulation were done to determine the market size of the segments and sub-segments.
Secondary Research
This research study involved the use of extensive secondary sources, directories, and databases, such as Hoover’s, Bloomberg BusinessWeek, Factiva, and OneSource, to identify and collect information useful for a technical, market-oriented, and commercial study of the compression therapy market. The other secondary sources included annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, manufacturer associations, trade directories, and databases.
Primary Research
The compression therapy market comprises several stakeholders, such as end-product manufacturers, raw material providers, and end-users in the supply chain. The demand-side of this market is characterized by its end-users, such as hospitals & clinics, pharmacies and retailers, e-commerce platforms, among others. The supply-side is characterized by raw material providers, integrators, and others. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The breakdown of primary respondents are given below:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches have been used to estimate and validate the size of the compression therapy market and its dependent submarkets. These methods were also used extensively to determine the extent of various sub-segments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and demand have been identified through extensive secondary research, and their market share has been determined through both primary and secondary research.
- The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
- All the possible parameters that affect the market segments covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
- The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.
Data Triangulation
After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. To complete the whole market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the end-use industries.
Report Objectives
- To define, describe, and forecast the compression therapy market based on product, technique, application, distribution channel, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall compression therapy market
- To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the revenue of the market segments with respect to five major regions and their countries—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To strategically profile the key global players and comprehensively analyze their market shares and core competencies
- To track and analyze competitive developments such as product launches, upgrades, and approvals; partnerships, agreements, and collaborations; acquisitions; and expansions in the compression therapy market
- To benchmark players within the market using the proprietary Competitive Leadership Mapping framework, which analyzes players on various parameters within the broad categories of business and product excellence strategy
To know about the assumptions considered for the study, Request for Free Sample Report
Available Customizations:
With the given market data, MarketsandMarkets offers customizations as per the client’s specific needs. The following customization options are available for the compression therapy market report:
Regional Analysis
- Further breakdown of region or country-specific analysis
Company Information
- Detailed analyses and profiling of additional market players (up to 5)
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Compression Therapy Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Compression Therapy Market
Can you share more about how key players are able to retain their position in the global Compression Therapy Market?
Global Compression Therapy Market Size, Forecast 2026. Its data on Market Projection By Technology, Major key players, Growth, Revenue, CAGR, Regional Analysis, Industry Forecast